This study investigates the levels of antibodies, which are proteins in the blood that help fight infections, in children with cirrhosis who have been vaccinated against hepatitis A and B. Cirrhosis is a condition where the liver becomes damaged and scarred, affecting its ability to function properly. The purpose is to understand how well these children are protected by the vaccines they received.
Participants will have their blood tested to measure the levels of antibodies for hepatitis A and B. This will help researchers understand the immune response in children with liver damage who have received vaccinations.
- Who can participate: Children aged X to Y with cirrhosis who have completed the vaccination series for hepatitis A, hepatitis B, or both are eligible to participate.
- Study details: Participants will undergo blood tests to measure the levels of antibodies for hepatitis A and B. These tests will help assess the effectiveness of the vaccinations in children with cirrhosis.
